deltatrials
Completed PHASE4 INTERVENTIONAL 1-arm NCT05399212

Composition for Treating Spermatogenesis and Semen Disorders / FPT-20

A New Natural Origin Product, Achieving More Than 80% Efficiency in Spermatogenesis in the Seminiferous Tubules. This Method Opens up Hope for Cases of Infertility Caused by the Inability of Spermatogonia to Develop Into Mature Sperm.

Sponsor: TRAN MINH DUC, MD

Conditions Spermatogenesis and Semen Disorders
Interventions FPT-20
Updated 5 times since 2022 Last updated: May 13, 2025 Started: Oct 29, 2020 Primary completion: May 20, 2022 Completion: May 20, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Spermatogenesis and Semen Disorders, this trial is completed. The trial is conducted by TRAN MINH DUC, MD and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jul 2022 – ~Jul 2024 · 24 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Jun 2025 · 7 months · monthly snapshotCompleted~Jun 2025 – present · 14 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Jun 2025 — Present [monthly]

    Completed PHASE4

    Phase: NA → PHASE4

  2. Nov 2024 — Jun 2025 [monthly]

    Completed NA

  3. Sep 2024 — Nov 2024 [monthly]

    Completed NA

  4. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  5. Jul 2022 — Jul 2024 [monthly]

    Completed NA

    First recorded

Oct 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • TRAN MINH DUC, MD
  • Trieu, Nguyen Thi, M.D.
Data source: Trieu, Nguyen Thi, M.D.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations